Offerings / Regulation CF / EpiBone, Inc.
EpiBone, Inc.
Regulation Crowdfunding offering on Wefunder · Form C filed October 15, 2026 · New York, New York
Repeat issuerPreferredEarly revenueCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on July 17, 2013, based in New York, NY, with 8 employees and $479,453 of revenue in its most recent fiscal year.
Offering terms
- Security
- Preferred Stock
- Maximum
- $1,235,000.00
- Price
- $1.14 per unit
- Pricing method
- Dividing pre-money valuation $122,063,490.00 (or $107,406,911.00 for investors in the first $320,000) by number of shares outstanding on fully diluted basis.
- Deadline
- April 30, 2027
- Oversubscriptions
- Accepted
- Intermediary
- Wefunder Portal LLC
Funding portal, SEC file 007-00033 - Intermediary fee
- 5.9% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
- Intermediary equity
- No
- Co-issuer
- EpiBone II, a series of Wefunder SPV, LLC
EpiBone II EB, a series of Wefunder SPV, LLC
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $479,453 | $29,949 |
| Cost of goods sold | $0 | $0 |
| Net income (loss) | -$1,981,452 | -$5,441,706 |
| Total assets | $4,075,356 | $1,426,379 |
| Cash and equivalents | $3,874,484 | $1,282,564 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $2,477,177 | $278,577 |
| Long-term debt | $247,963 | $1,999,990 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 8 employees. Offered in 56 states.